BioSpace News Archive

Blue Earth Diagnostics Completes Patient Accrual in Phase 3 REVELATE Clinical Trial of 18 F-Fluciclovine PET Imaging for Detection of Recurrent Brain Metastases.

Erez to Help Grow PixCell’s Business Across the Globe and Support Strategic Planning.

Accord Healthcare, Inc., a leading generic pharmaceutical company, has added Vilazodone to its oral tablets portfolio.

Rebus Biosystems Inc, an Illumina Ventures-backed life science technology company creating revolutionary tools to advance spatial omics research, announced it is partnering with Rosalind, Inc. to co-develop new spatial omics software.

Nanosonics, a leader in infection prevention solutions, announced that patients in North America have been protected from the risk of ultrasound probe cross-contamination in over 100 million trophon® high level disinfection procedures.

Acutis Diagnostics, a New York State laboratory, is taking on urgent healthcare issues through advancing medical testing capabilities.

Kyowa Kirin, Inc., an affiliate of Kyowa Kirin Co., Ltd. a global specialty pharmaceutical company, will host a virtual roundtable discussion, Challenging Disparities in Cancer Care — Lessons for Cutaneous Lymphomas and Other Patient Communities, on June 14, 2022, 12:00 – 1:30 p.m. ET, ahead of National Black Family Cancer Awareness Week.

Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous system diseases, announced that Craig Thompson, chief executive officer of Cerevance, will participate in a panel discussion during the 2022 BIO International Convention being held in San Diego, CA, June 13-16.

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

Antibody drug conjugates are the new drug class which exploits the specificity of monoclonal antibodies to reach target antigens expressed on cancer cells for the delivery of a potent cytotoxic payload.